UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy of Intra-Articular Injection of Botulinum Toxin Type A in Refractory Hemiplegic Shoulder Pain

Archives of physical medicine and rehabilitation, 2011-07, Vol.92 (7), p.1034-1037

2011

Volltextzugriff (PDF)

Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective multi-centric study

Journal of neurotrauma, 2012-07, Vol.29 (11), p.2050-2059

2012

Volltextzugriff (PDF)

Life-Threatening Constipation Induced by Intrathecal Baclofen Therapy

European neurology, 2008-01, Vol.60 (2), p.95-96

2008

Volltextzugriff (PDF)

Treatment of cardiac transthyretin amyloidosis: an update

European heart journal, 2019-12, Vol.40 (45), p.3699-3706

2019

Volltextzugriff (PDF)

The Seurat spleen

Abdominal radiology (New York), 2021-07, Vol.46 (7), p.3515-3516

2021

Volltextzugriff (PDF)

Biomarkers for the diagnosis and management of heart failure

Heart failure reviews, 2022-03, Vol.27 (2), p.625-643

2022

Volltextzugriff (PDF)

Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician

International journal of cardiology, 2024-05, Vol.402, p.131855-131855, Article 131855

2024

Volltextzugriff (PDF)

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

European journal of internal medicine, 2020-10, Vol.80, p.66-72

2020

Volltextzugriff (PDF)

Use of biomarkers to diagnose and manage cardiac amyloidosis

European journal of heart failure, 2021-02, Vol.23 (2), p.217-230

2021

Volltextzugriff (PDF)

Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is

European journal of heart failure, 2022-05, Vol.24 (5), p.791-793

2022

Volltextzugriff (PDF)

RNA-targeting and gene editing therapies for transthyretin amyloidosis

Nature reviews cardiology, 2022-10, Vol.19 (10), p.655-667

2022

Volltextzugriff (PDF)

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

Heart failure reviews, 2021-07, Vol.26 (4), p.881-890

2021

Volltextzugriff (PDF)

Real-Time Fluoroscopic Needle Guidance Software Application for Cisterna Chyli Puncture in Lymphatic Interventions by the use of Tailored Route: Proof of Concept

Cardiovascular and interventional radiology, 2022-03, Vol.45 (3), p.395-397

2022

Volltextzugriff (PDF)

Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio

International journal of cardiology, 2024-07, Vol.407, p.132039-132039, Article 132039

2024

Volltextzugriff (PDF)

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2020-10, Vol.76 (15), p.1795-1807

2020

Volltextzugriff (PDF)

Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’

European journal of heart failure, 2020-10, Vol.22 (10), p.1934-1935

2020

Volltextzugriff (PDF)

Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines

European journal of heart failure, 2022-06, Vol.24 (6), p.916-926

2022

Volltextzugriff (PDF)

Cooperative Intersection Crossing Over 5G

IEEE/ACM transactions on networking, 2021-02, Vol.29 (1), p.303-317

2021

Volltextzugriff (PDF)

Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?

European journal of heart failure, 2022-07, Vol.24 (7), p.1209-1211

2022

Volltextzugriff (PDF)

Critical Reading of cardiovascular trials with neutral or negative results

European heart journal, 2023-10, Vol.44 (40), p.4230-4232

2023

Volltextzugriff (PDF)

TEMPO-Nanocellulose/Ca2+ Hydrogels: Ibuprofen Drug Diffusion and In Vitro Cytocompatibility

Materials, 2020-01, Vol.13 (1), p.183

2020

Volltextzugriff (PDF)

Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?

International journal of cardiology, 2022-09, Vol.363, p.127-128

2022

Volltextzugriff (PDF)

Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6594

2022

Volltextzugriff (PDF)

Current and emerging drug targets in heart failure treatment

Heart failure reviews, 2022-07, Vol.27 (4), p.1119-1136

2022

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Efficacy of Intra-Articular Injection of Botulinum Toxin Type A in Refractory Hemiplegic Shoulder Pain

Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective multi-centric study

Life-Threatening Constipation Induced by Intrathecal Baclofen Therapy

Treatment of cardiac transthyretin amyloidosis: an update

The Seurat spleen

Biomarkers for the diagnosis and management of heart failure

Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinician

Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis

Safety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis

Use of biomarkers to diagnose and manage cardiac amyloidosis

Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is

RNA-targeting and gene editing therapies for transthyretin amyloidosis

Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets

Real-Time Fluoroscopic Needle Guidance Software Application for Cisterna Chyli Puncture in Lymphatic Interventions by the use of Tailored Route: Proof of Concept

Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week

Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’

Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines

Cooperative Intersection Crossing Over 5G

Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?

Critical Reading of cardiovascular trials with neutral or negative results

TEMPO-Nanocellulose/Ca2+ Hydrogels: Ibuprofen Drug Diffusion and In Vitro Cytocompatibility

Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?

Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway

Current and emerging drug targets in heart failure treatment

Suchergebnisse filtern